Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant-Reference-Cited by-同舟云学术

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Published:2019-09 Issue:9 Volume:25 Page:1832-1836
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Gokarn Anant,Toshniwal Anup,Pathak Amogh,Arora Sankalp,Bonda Avinash,Punatar Sachin,Nayak Lingaraj^ORCID,Dwivedi Pankaj,Bhat Vivek,Biswas Sanjay,Kelkar Rohini,Kannan Sadhana,Khattry Navin

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference17 articles.

1. Cytomegalovirus viremia and relapse after haploidentical hematopoietic cell transplantation;Goldsmith;Biol Blood Marrow Transplant,2016

2. Prevention of cytomegalovirus reactivation in haploidentical stem cell transplantation;Hammerstrom;Biol Blood Marrow Transplant,2018

3. Cytomegalovirus infection;Zaia,2016

4. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection;Nichols;J Infect Dis,2002

5. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India;Kothari;J Health Popul Nutr,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections in Hematopoietic Stem Cell Transplant Recipients in India – Think Global, Act Local;Journal of Clinical Infectious Disease Society;2024-07

2. Cytomegalovirus Infections in Hematopoietic Cell Transplant and Solid Organ Transplant Recipients;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

3. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20

4. Oral Versus Intravenous Anti-CMV Preemptive Strategies in Allogeneic Stem Cell Transplant Patients with CMV Reactivation: Experience from the National Center of Bone Marrow Transplantation, Tunis, Tunisia;OBM Transplantation;2023-09-12

5. An open-label randomized controlled trial of leflunomide in patients with acute SARS-CoV-2 omicron variant infection;Frontiers in Medicine;2023-07-18